Ke Mou and Stephen Zou of Liu Shen & Associates outline China’s evolving framework on pharmaceutical intellectual property ...

Loke Khoon Tan and Stephanie Yip at Dentons explain what brand owners need to know ahead of January 1 2027, when updates to ...

Anna Mae Koo and Owen Tse of Vivien Chan & Co examine how trademarks, personality rights, and AI regulations can help ...

Octavio Espejo of Becerril, Coca & Becerril explains how sweeping patent reforms reshape filing strategies, prosecution, and divisional application practice ...

Richard Quatrano, counsel at Olshan Frome Wolosky, shares why technology M&A buyers and sellers must verify written IP ...

Appointment of AI and copyright expert Anna Naydonov, as well as another partner from Orrick, show how firms can attract top ...

Vera Albino of Inventa explores how Portuguese wine producers use seemingly offensive names rooted in local history and ...

Selin Sinem Erciyas of Gün + Partners examines whether the EU Pharma Package’s expanded Bolar exemption aligns with the TRIPS ...

Fabio Angelini of Bugnion SpA examines whether the Kentucky ruling by the EUIPO Fourth Board of Appeal can be reconciled with ...

The departure of a large chunk of Spruson & Ferguson's legacy leadership could have destabilised the firm, but it's fighting ...

Igor Charles and Théo Coquis of INLEX analyse a Paris Judicial Court ruling confirming that trademark exhaustion applies to ...

Kerstin Wolff of Maiwald explains how patents, plant variety rights, and new genomic techniques intersect in Europe, and what ...